KALVISTA PHARMA Balance Sheet - Annual (NASDAQ:KALV)

Add to My Stocks
$16.26 $0.18 (1.12%) KALV stock closing price Sep 19, 2018 (Closing)

A thorough fundamental analysis involves using data from KALVISTA PHARMA balance sheet, apart from other financial statements, to value the business. A balance sheet can help evaluate the financial performance of a company. Ratios like return on total assets and current ratio, which also uses cash on hand can be used to measure the operating efficiency of a firm, and can be used to conduct a more accurate KALVISTA PHARMA stock analysis. Good annual results indicate a company's strong financial performance. Its important to check all financial statements including the balance sheet. KALVISTA PHARMA balance sheet indicates an asset turnover ratio of - and debt to equity ratio of -. Also check KALVISTA PHARMA revenue and KALVISTA PHARMA operating cash flow for the same period.

View latest 10 year balance sheet data to check KALVISTA PHARMA financial performance.
show more
Fiscal year is May - Apr2017201620152014
Cash30.95M21.76M--
Marketable Securities----
Receivables2.54M2.23M--
Inventory----
Raw Materials----
Work In Progress----
Finished Goods----
Notes Receivable----
Other Current Assets----
Total Current Assets
34.24M24.67M--
Property Plant & Equipment----
Accumulated Depreciation----
Net Property Plant & Equipment
----
Investment & Advances----
Other Non-Current Assets----
Deferred Charges----
Intangibles----
Deposits & Other Assets----
Total Assets
34.34M24.74M--
Notes Payable----
Accounts Payable1.15M1M--
Current Portion Long-Term Debt----
Current Portion Capital Leases----
Accrued Expenses1.86M2.11M--
Income Taxes Payable----
Other Current Liabilities----
Total Current Liabilities
3.01M3.24M--
Mortgages----
Deferred Taxes/Income----
Convertible Debt----
Long-Term Debt----
Non-Current Capital Leases----
Other Long-Term Liabilities----
Total Liabilities
3.01M3.24M--
Minority Interest----
Preferred Stock-58.6M--
Common Stock Net----
Capital Surplus89.81M---
Retained Earnings-55.85M-37.25M--
Treasury Stock----
Other Liabilities-2.64M-0.07M--
Shareholders Equity31.32M21.49M--
Total Liabilities & Shareholders Equity34.34M24.74M--
All figures in USD. M: Millions of USD, B: Billions of USD.

Click here to view our Durect financial analysis

Looking at KALVISTA PHARMA historical stock prices and the current KALVISTA PHARMA stock price can tell you how the stock price has moved, whereas the KALVISTA PHARMA PE ratio chart shows if its shares are overpriced in comparison to peers. The important things to look for in a balance sheet are:

  • Assets: Anything that the KALVISTA PHARMA company owns and is a part of its books. Assets can be of three types: fixed, current and other assets which includes intangibles, advances. Internet companies typically don't have a lot of assets as there is not much investment in say machinery, equipment etc. KALVISTA PHARMA had total assets of $34.34M.
  • Liabilities: The total liabilities of KALVISTA PHARMA for the year 2017 total to $3.01M. Liabilities for a company like KALVISTA PHARMA include bank loans, services which have been availed for which a settlement in the form of cash/ asset transfer needs to be done in future etc. A firm takes on such obligations to grow its business which in turn will generate future economic benefits for its business.

KALVISTA PHARMA Balance Sheet - Key Ratios

Current ratio
0
Debt to equity ratio
0
Asset turnover ratio
0
Receivables turnover
0

Annual Balance Sheets For KALVISTA PHARMA Peers

ALLERGY THERAPT balance sheet, Durect balance sheet, Zynex balance sheet